Achim Freisleben

525 total citations
13 papers, 312 citations indexed

About

Achim Freisleben is a scholar working on Rheumatology, Immunology and Clinical Biochemistry. According to data from OpenAlex, Achim Freisleben has authored 13 papers receiving a total of 312 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Rheumatology, 4 papers in Immunology and 3 papers in Clinical Biochemistry. Recurrent topics in Achim Freisleben's work include Folate and B Vitamins Research (5 papers), Biosimilars and Bioanalytical Methods (4 papers) and Metabolism and Genetic Disorders (3 papers). Achim Freisleben is often cited by papers focused on Folate and B Vitamins Research (5 papers), Biosimilars and Bioanalytical Methods (4 papers) and Metabolism and Genetic Disorders (3 papers). Achim Freisleben collaborates with scholars based in Germany, United States and Denmark. Achim Freisleben's co-authors include Michael Rychlik, Peter Schieberle, Philip Timmerman, Morten A. Kall, Ben Gordon, Sirpa Laakso, Ronald de Vries, Andreas Johne, Sonja Krösser and Hugues Dolgos and has published in prestigious journals such as Analytical Biochemistry, Journal of Agricultural and Food Chemistry and Analytical and Bioanalytical Chemistry.

In The Last Decade

Achim Freisleben

13 papers receiving 289 citations

Peers

Achim Freisleben
N. Raica United States
Bradley Winston United States
Lesley J. Hinks United Kingdom
P P Sokol United States
Barbara B. Bowman United States
Arne Gessner Germany
Achim Freisleben
Citations per year, relative to Achim Freisleben Achim Freisleben (= 1×) peers Gabriele Pontoni

Countries citing papers authored by Achim Freisleben

Since Specialization
Citations

This map shows the geographic impact of Achim Freisleben's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Achim Freisleben with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Achim Freisleben more than expected).

Fields of papers citing papers by Achim Freisleben

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Achim Freisleben. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Achim Freisleben. The network helps show where Achim Freisleben may publish in the future.

Co-authorship network of co-authors of Achim Freisleben

This figure shows the co-authorship network connecting the top 25 collaborators of Achim Freisleben. A scholar is included among the top collaborators of Achim Freisleben based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Achim Freisleben. Achim Freisleben is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Kall, Morten A., et al.. (2018). Incurred Sample Reproducibility: 10 Years of Experiences: Views and Recommendations from the European Bioanalysis Forum. Bioanalysis. 10(21). 1723–1732. 13 indexed citations
2.
Wilson, Amanda, Achim Freisleben, Sirpa Laakso, et al.. (2018). European Bioanalysis Forum Recommendation on the Best Practices to Demonstrate Processed Sample Stability. Bioanalysis. 11(1). 7–11. 1 indexed citations
3.
Dolgos, Hugues, et al.. (2016). In vitro and in vivo drug disposition of cilengitide in animals and human. Pharmacology Research & Perspectives. 4(2). e00217–e00217. 8 indexed citations
5.
Johne, Andreas, et al.. (2013). Absolute Bioavailability and Effect of Food on the Disposition of Safinamide Immediate Release Tablets in Healthy Adult Subjects. Clinical Pharmacology in Drug Development. 2(1). 79–89. 15 indexed citations
6.
Freisleben, Achim, et al.. (2011). Blood Stability Testing: European Bioanalysis Forum View on Current Challenges for Regulated Bioanalysis. Bioanalysis. 3(12). 1333–1336. 23 indexed citations
8.
Timmerman, Philip, et al.. (2010). Best Practices in a Tiered Approach to Metabolite Quantification: Views and Recommendations of The European Bioanalysis Forum. Bioanalysis. 2(7). 1185–1194. 55 indexed citations
9.
Freisleben, Achim, Peter Schieberle, & Michael Rychlik. (2003). Specific and Sensitive Quantification of Folate Vitamers in Foods by Stable Isotope Dilution Assays.. Analytical and Bioanalytical Chemistry. 149–156. 1 indexed citations
11.
Freisleben, Achim, Peter Schieberle, & Michael Rychlik. (2003). Specific and sensitive quantification of folate vitamers in foods by stable isotope dilution assays using high-performance liquid chromatography-tandem mass spectrometry. Analytical and Bioanalytical Chemistry. 376(2). 149–156. 80 indexed citations
12.
Freisleben, Achim, Peter Schieberle, & Michael Rychlik. (2002). Syntheses of Labeled Vitamers of Folic Acid to Be Used as Internal Standards in Stable Isotope Dilution Assays. Journal of Agricultural and Food Chemistry. 50(17). 4760–4768. 41 indexed citations
13.
Rychlik, Michael & Achim Freisleben. (2002). Quantification of Pantothenic Acid and Folates by Stable Isotope Dilution Assays. Journal of Food Composition and Analysis. 15(4). 399–409. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026